Literature DB >> 23867918

Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.

Rongjuan Pei1, Bo Qin, Xiaoyong Zhang, Wandi Zhu, Thekla Kemper, Zhiyong Ma, Martin Trippler, Joerg Schlaak, Xinwen Chen, Mengji Lu.   

Abstract

Interferon (IFN)-α is able to stimulate many cellular genes and inhibit the replication of various viruses. However, it is unknown whether some IFN-stimulated genes (ISGs) specifically inhibit hepatitis B virus (HBV) replication. Therefore, we attempted to identify ISGs with antiviral activities against HBV. Knockdown of IFN-induced proteins with tetratricopeptide repeats 1 and 2 (IFIT1 and IFIT2) in HepG2.2.15 led to markedly increased HBV replication. Consistently, this effect was verified by transient transfection with a replication-competent HBV clone in HepG2 and Huh7. However, IFN-α stimulation could override the knockdown by siRNAs and enhance the expression of IFIT1 and IFIT2, leading to reduced HBV replication. Silencing of IFIT1 or IFIT2 decreased the expression of the corresponding genes while other ISGs like MxA were not affected. Northern blot analysis showed that IFIT1 and IFIT2 knockdown slightly increased the levels of HBV 3.5, 2.4 and 2.1 kb transcripts, while IFIT1 and IFIT2 overexpression did not change their levels. Consistently, the reporter assays with HBV promoters demonstrated that IFIT1 and IFIT2 differentially but only modestly regulated HBV promoter activity. Thus, IFIT1 and IFIT2 contribute significantly to the regulation of HBV replication, likely at both transcriptional and posttranscriptional steps.
Copyright © 2013 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867918      PMCID: PMC6741538          DOI: 10.1159/000353220

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  17 in total

1.  RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon Element.

Authors:  Zhe Wen; Chunchen Wu; Xinwen Chen; Yongxuan Yao; Bo Yang; Yingshan Chen; Hui Wang; Xue Hu; Yuan Zhou; Xiuzhu Gao; Mengji Lu; Junqi Niu
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells.

Authors:  Jiradej Makjaroen; Poorichaya Somparn; Kenneth Hodge; Witthaya Poomipak; Nattiya Hirankarn; Trairak Pisitkun
Journal:  Mol Cell Proteomics       Date:  2018-08-10       Impact factor: 5.911

3.  Assessment of Cytokine-Mediated Signaling Pathway Dysregulation in Arm Skin After CO2 Laser Therapy.

Authors:  Mohammad Rostami-Nejad; Mostafa Rezaei-Tavirani; Mohammad-Mehdi Zadeh-Esmaeel; Sina RezaeiTavirani; Zahra Akbari; Somayeh Esmaeili; Farshad Okhovatian
Journal:  J Lasers Med Sci       Date:  2019-10-01

Review 4.  Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.

Authors:  Rong-Juan Pei; Xin-Wen Chen; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  A haplotype variant of porcine IFIT2 increases poly(I:C)-induced activation of NF-κB and ISRE-binding factors.

Authors:  Yu Pang; Caixia Zhang; Yaguang Tian; Yanfang Song; Di Liu; Xiuqin Yang
Journal:  Mol Biol Rep       Date:  2018-10-08       Impact factor: 2.316

6.  The identification of neutrophils-mediated mechanisms and potential therapeutic targets for the management of sepsis-induced acute immunosuppression using bioinformatics.

Authors:  Fang Chen; Chunyan Yao; Yue Feng; Ying Yu; Honggang Guo; Jing Yan; Jin Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

Review 7.  Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.

Authors:  Anna D Kosinska; Jia Liu; Mengji Lu; Michael Roggendorf
Journal:  Med Microbiol Immunol       Date:  2014-12-23       Impact factor: 3.402

8.  Interferon-Stimulated Gene 15 Conjugation Stimulates Hepatitis B Virus Production Independent of Type I Interferon Signaling Pathway In Vitro.

Authors:  Yujia Li; Shilin Li; Xiaoqiong Duan; Yanzhao Chen; Baihai Jiao; Haiyan Ye; Min Yao; Limin Chen
Journal:  Mediators Inflamm       Date:  2016-10-27       Impact factor: 4.711

9.  MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.

Authors:  Shuhui Liu; Kaitao Zhao; Xi Su; Lu Lu; He Zhao; Xianwen Zhang; Yun Wang; Chunchen Wu; Jizheng Chen; Yuan Zhou; Xue Hu; Yanyi Wang; Mengji Lu; Xinwen Chen; Rongjuan Pei
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

10.  IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection.

Authors:  Dong-Ying Xie; Shi-Ming Wang; Jing-Min Yang; Liang-Hui Wang; Hong-Yan Chen; Cong Huai; Jia Shang; Qing Mao; Chun-Liang Lei; Guang-Han Luo; Ji Qian; Da-Ru Lu
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.